NM_015346.4(ZFYVE26):c.4305G>A (p.Val1435=) AND Spastic paraplegia
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Nov 12, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001439016.7
Allele description [Variation Report for NM_015346.4(ZFYVE26):c.4305G>A (p.Val1435=)]
NM_015346.4(ZFYVE26):c.4305G>A (p.Val1435=)
Condition(s)
- Name:
- Spastic paraplegia
- Identifiers:
- MedGen: C0037772; Human Phenotype Ontology: HP:0001258
-
Stenotrophomonas sp. VM7 16S ribosomal RNA gene, partial sequence
Stenotrophomonas sp. VM7 16S ribosomal RNA gene, partial sequencegi|333827842|gb|JF717762.1|Nucleotide
-
Sedum caeruleum (37)
Nucleotide
-
1,2-phenylacetyl-CoA epoxidase subunit PaaD [Burkholderia pseudomallei]
1,2-phenylacetyl-CoA epoxidase subunit PaaD [Burkholderia pseudomallei]gi|490671220|ref|WP_004536209.1|Protein
-
target of EGR1 protein 1 isoform X2 [Homo sapiens]
target of EGR1 protein 1 isoform X2 [Homo sapiens]gi|2462502645|ref|XP_054190040.1|Protein
-
PREDICTED: Homo sapiens target of EGR1, exonuclease (TOE1), transcript variant X...
PREDICTED: Homo sapiens target of EGR1, exonuclease (TOE1), transcript variant X5, mRNAgi|2462502650|ref|XM_054334068.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024